Table 3.

Natural killer (NK), NKG2D and killer cell immunoglobulin-like receptor (KIR3)DL1 cells in relation to presence of the type 1 diabetes (T1D) risk human leucocyte antigen (HLA)-DQB1*0302.

	LADA patients with T1D risk HLA-DQB1*0302
	Yes	No
NK cell subset, NKG2D or KIR3DL1 expression in high levels*	n (% of patients with high levels)	n (% of patients with high levels)	P-value
NK cells (% of total)	10 (52%)	14 (44%)	0·57
NKG2D cells (% of total)	12 (75%)	7 (32%)	0·009
NKG2D cells (% of NK cells)	10 (63%)	9 (41%)	0·19
KIR3DL cells (% of total)	6 (38%)	13 (59%)	0·19
KIR3DL cells (% of NK cells)	6 (38%)	13 (59%)	0·19

^*Patients with high levels have percentages above median (see Fig. 2). LADA, latent autoimmune diabetes in adults.